The Experts below are selected from a list of 34737 Experts worldwide ranked by ideXlab platform

Roberta M Kato - One of the best experts on this subject based on the ideXlab platform.

  • a physician survey reveals differences in management of idiopathic pulmonary hemosiderosis
    Orphanet Journal of Rare Diseases, 2015
    Co-Authors: Chana I C Chin, Shirleen Loloyan Kohn, Thomas G Keens, Monique F Margetis, Roberta M Kato
    Abstract:

    Background Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder of unknown etiology characterized by chronic pulmonary hemorrhage and presents with a triad of anemia, hemoptysis and pulmonary infiltrates. IPH is a Diagnosis of Exclusion with a variable and disparate clinical course. Despite existing therapies, few children achieve full remission while others have recurrent hemorrhage, progressive lung damage, and premature death.

Joshua Eisenberg - One of the best experts on this subject based on the ideXlab platform.

  • median arcuate ligament syndrome review of this rare disease
    JAMA Surgery, 2016
    Co-Authors: Erinn N Kim, Kathleen M Lamb, Daniel Relles, Neil Moudgill, Paul Dimuzio, Joshua Eisenberg
    Abstract:

    Importance Median arcuate ligament (MAL) syndrome is a rare disease resulting from compression of the celiac axis by fibrous attachments of the diaphragmatic crura, the median arcuate ligament. Diagnostic workup and therapeutic intervention can be challenging. Objective To review the literature to define an algorithm for accurate Diagnosis and successful treatment for patients with MAL syndrome. Evidence Review A search of PubMed (1995-September 28, 2015) was conducted, using the key terms median arcuate ligament syndrome and celiac artery compression syndrome . Findings Typically a Diagnosis of Exclusion, MAL syndrome involves a vague constellation of symptoms including epigastric pain, postprandial pain, nausea, vomiting, and weight loss. Extrinsic compression of the vasculature and surrounding neural ganglion has been implicated as the cause of these symptoms. Multiple imaging techniques can be used to demonstrate celiac artery compression by the MAL including mesenteric duplex ultrasonography, computed tomography angiography, magnetic resonance angiography, gastric tonometry, and mesenteric arteriography. Surgical intervention involves open, laparoscopic, or robotic ligament release; celiac ganglionectomy; and celiac artery revascularization. There remains a limited role for angioplasty because this intervention does not address the underlying extrinsic compression resulting in symptoms, although angioplasty with stenting may be used in recalcitrant cases. Conclusions and Relevance Median arcuate ligament syndrome is rare, and as a Diagnosis of Exclusion, Diagnosis and treatment paradigms can be unclear. Based on previously published studies, symptom relief can be achieved with a variety of interventions including celiac ganglionectomy as well as open, laparoscopic, or robotic intervention.

Monique F Margetis - One of the best experts on this subject based on the ideXlab platform.

  • a physician survey reveals differences in management of idiopathic pulmonary hemosiderosis
    Orphanet Journal of Rare Diseases, 2015
    Co-Authors: Chana I C Chin, Shirleen Loloyan Kohn, Thomas G Keens, Monique F Margetis, Roberta M Kato
    Abstract:

    Background Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder of unknown etiology characterized by chronic pulmonary hemorrhage and presents with a triad of anemia, hemoptysis and pulmonary infiltrates. IPH is a Diagnosis of Exclusion with a variable and disparate clinical course. Despite existing therapies, few children achieve full remission while others have recurrent hemorrhage, progressive lung damage, and premature death.

Thomas G Keens - One of the best experts on this subject based on the ideXlab platform.

  • a physician survey reveals differences in management of idiopathic pulmonary hemosiderosis
    Orphanet Journal of Rare Diseases, 2015
    Co-Authors: Chana I C Chin, Shirleen Loloyan Kohn, Thomas G Keens, Monique F Margetis, Roberta M Kato
    Abstract:

    Background Idiopathic pulmonary hemosiderosis (IPH) is a rare disorder of unknown etiology characterized by chronic pulmonary hemorrhage and presents with a triad of anemia, hemoptysis and pulmonary infiltrates. IPH is a Diagnosis of Exclusion with a variable and disparate clinical course. Despite existing therapies, few children achieve full remission while others have recurrent hemorrhage, progressive lung damage, and premature death.

Seweryna Konieczna - One of the best experts on this subject based on the ideXlab platform.

  • paediatric tolosa hunt syndrome the need for treatment guidelines and renewed criteria
    Developmental Medicine & Child Neurology, 2010
    Co-Authors: Karolina Pienczkreclawowicz, Ewa Pilarska, Malgorzata Lemka, Seweryna Konieczna
    Abstract:

    SIR–Tolosa-Hunt syndrome (THS) is a rare disorder, especially in the paediatric population, characterized by unilateral painful ophthalmoplegia of, typically, a relapsing-remitting course and a substantial response to corticosteroids. The symptoms of THS are not specific and clinical criteria themselves do not guarantee a firm Diagnosis. Neuroimaging or biopsy confirming granulomatous inflammation is essential to ad iagnosis of THS. Although diagnostic criteria were established by the International Headache Society in 1988, then revised in 2004 (Table I), 1 THS remains a Diagnosis of Exclusion of other causes of painful ophthalmoplegia, (e.g. neoplasms, aneurysms, cranial neuropathy [diabetes mellitus], opthalmoplegic migraine, intracranial vasculitis, pseudotumor of the orbit, basal meningitis, or cavernous sinus thrombosis). 2